NR1H4 and metabolic dysfunction-associated steatotic liver disease: This is largely due to evidence that BAs can act as key signalling molecules that regulate glucose and lipid metabolism via receptors such as the farnesoid X receptor (FXR) and may therefore influence NAFLD at multiple levels, as reviewed in more detail elsewhere.53